Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9067981 Hybrid amyloid-beta antibodies

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
October 29, 2009
0
Date of Patent
June 30, 2015
0
Patent Application Number
12608869
0
Patent Citations Received
‌
US Patent 12071472 Methods of reducing toxicity induced by Amyloid beta (A-beta) oligomers using antibodies specific to A-beta oligomers
0
‌
US Patent 11779629 Compositions comprising cyclic peptides derived from an A-beta peptide
‌
US Patent 11905318 Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide
0
‌
US Patent 11970522 Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide
0
Patent Inventor Names
Dale B. Schenk
0
Hadar Hana Feinberg
0
William I. Weis
0
Guriqbal Basi
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9067981
0
Patent Primary Examiner
‌
Kimberly A Ballard
0

Find more entities like US Patent 9067981 Hybrid amyloid-beta antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.